Cinctive Capital Management LP Guardant Health, Inc. Transaction History

Cinctive Capital Management LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $332,569 - $454,624	15,411 New	15,411 $416,000
Q4 2022 Feb 14, 2023	SELL	$25.44 - $59.78 $309,630 - $727,582	-12,171 Reduced 33.75%	23,890 $649,000
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $3.95 Million - $5.52 Million	-90,548 Reduced 71.52%	36,061 $1.94 Million
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $2.4 Million - $6.44 Million	83,208 Added 191.72%	126,609 $5.11 Million
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $462,235 - $962,694	9,580 Added 28.33%	43,401 $2.88 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $3 Million - $4.07 Million	33,821 New	33,821 $3.38 Million
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $2.8 Million - $3.74 Million	-28,300 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $3.11 Million - $4.69 Million	28,300 New	28,300 $3.52 Million
Q1 2021 May 17, 2021	SELL	$127.04 - $179.1 $4.56 Million - $6.42 Million	-35,855 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $766,693 - $1.04 Million	7,670 Added 27.21%	35,855 $4.62 Million
Q3 2020 Nov 16, 2020	BUY	$80.32 - $111.8 $2.26 Million - $3.15 Million	28,185 New	28,185 $3.15 Million

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.